Department of Pediatric Hematology and Oncology, University of Miami Miller School of Medicine, Miami, FL 33101, USA.
Leuk Res. 2010 Dec;34(12):1601-9. doi: 10.1016/j.leukres.2010.05.012. Epub 2010 Jun 9.
Acute Lymphoblastic Leukemia (ALL) non-random fusions influence clinical outcome and alter the accumulation of MTX-PGs in vivo. Analysis of primary ALL samples uncovered subtype-specific patterns of folate gene expression. Using an FPGS-luciferase reporter gene assay, we determined that E2A-PBX1 and TEL-AML1 expression decreased FPGS transcription. ChIP assays uncovered HDAC1, AML1, mSin3A, E2F, and Rb interactions with the FPGS promoter region. We demonstrate that FPGS expression is epigenetically regulated through binding of selected ALL fusions to a multiprotein complex, which also controls the cell cycle dependence of FPGS expression. This study provides insights into the pharmacogenomics of MTX in ALL subtypes.
急性淋巴细胞白血病(ALL)非随机融合影响临床结果,并改变体内 MTX-PGs 的积累。对原发性 ALL 样本的分析揭示了叶酸基因表达的亚型特异性模式。我们使用 FPGS-荧光素酶报告基因检测,确定 E2A-PBX1 和 TEL-AML1 的表达降低了 FPGS 转录。ChIP 检测揭示了 HDAC1、AML1、mSin3A、E2F 和 Rb 与 FPGS 启动子区域的相互作用。我们证明 FPGS 的表达是通过选择 ALL 融合与多蛋白复合物的结合来进行表观遗传调控的,该复合物还控制 FPGS 表达的细胞周期依赖性。这项研究为 ALL 亚型中甲氨蝶呤的药物基因组学提供了深入的了解。